No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 4.140
- -4.250-50.66%
Close Jun 18 16:00 ET
- 4.210
- +0.070+1.69%
Post 19:59 ET
293.99MMarket Cap-1269P/E (TTM)
6.400High3.930Low21.58MVolume6.290Open8.390Pre Close112.82MTurnover41.83%Turnover RatioLossP/E (Static)71.01MShares29.42052wk High0.64P/B213.59MFloat Cap3.93052wk Low--Dividend TTM51.59MShs Float87.190Historical High--Div YieldTTM29.44%Amplitude3.930Historical Low5.227Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Wedbush Downgrades Zentalis Pharmaceuticals(ZNTL.US) to Sell Rating, Cuts Target Price to $4
Wedbush analyst Robert Driscoll downgrades $Zentalis Pharmaceuticals(ZNTL.US)$ to a sell rating, and adjusts the target price from $15 to $4.According to TipRanks data, the analyst has a success rate
A Quick Look at Today's Ratings for Zentalis Pharmaceuticals(ZNTL.US), With a Forecast Between $6 to $25
On Jun 19, major Wall Street analysts update their ratings for $Zentalis Pharmaceuticals(ZNTL.US)$, with price targets ranging from $6 to $25.Morgan Stanley analyst Michael Ulz downgrades to a hold ra
Express News | Zentalis Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $8 From $15
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release,
Express News | Zentalis Pharmaceuticals Inc : Jefferies Cuts Target Price to $6 From $42
Express News | Zentalis Pharmaceuticals Inc : Jefferies Cuts to Hold From Buy
Comments
$Zentalis Pharmaceuticals(ZNTL.US$ only down because they put a hold on a drug they are working on , perhaps it's oversold at this point
1
The satisfactory 2.7 years cash runway is overshadowed by increased cash burn rate of 19%. The firm's potential to raise funds for growth via new shares may entail dilution of existing ones. Close monitoring of Zentalis Pharmaceuticals' cash burn situation advised.
Gainers:
• $Enphase Energy(ENPH.US$ +8.2% (earnings reports)
• $Zentalis Pharmaceuticals(ZNTL.US$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $Ternium(TX.US$ +6.1% (earnings reports)
• $PureCycle Technologies(PCT.US$ +5% (SEC concludes investigation without further action)
• $Alliance Resource(ARLP.US$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US$ +4.5% (cu...
• $Enphase Energy(ENPH.US$ +8.2% (earnings reports)
• $Zentalis Pharmaceuticals(ZNTL.US$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $Ternium(TX.US$ +6.1% (earnings reports)
• $PureCycle Technologies(PCT.US$ +5% (SEC concludes investigation without further action)
• $Alliance Resource(ARLP.US$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US$ +4.5% (cu...
14
1
Upgrades
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
7
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg